KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Times Interest Earned (2018 - 2025)

TherapeuticsMD's Times Interest Earned history spans 12 years, with the latest figure at -$287.33 for Q3 2025.

  • For Q3 2025, Times Interest Earned rose 23.99% year-over-year to -$287.33; the TTM value through Dec 2025 reached -$568.57, up 20.44%, while the annual FY2021 figure was -$3.53, 35.21% up from the prior year.
  • Times Interest Earned reached -$287.33 in Q3 2025 per TXMD's latest filing, up from -$347.5 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $12.76 in Q4 2021 to a low of -$557.8 in Q2 2024.
  • Average Times Interest Earned over 5 years is -$169.85, with a median of -$54.93 recorded in 2023.
  • Peak YoY movement for Times Interest Earned: surged 441.4% in 2021, then crashed 1500.65% in 2023.
  • A 5-year view of Times Interest Earned shows it stood at $12.76 in 2021, then tumbled by 126.11% to -$3.33 in 2022, then tumbled by 2560.24% to -$88.65 in 2023, then tumbled by 326.4% to -$378.0 in 2024, then rose by 23.99% to -$287.33 in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Times Interest Earned are -$287.33 (Q3 2025), -$347.5 (Q2 2025), and -$435.5 (Q1 2025).